Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of the following increases in interests in American Depositary Shares (ADSs) of GlaxoSmithKline plc purchased at a price of $47.617 per ADS, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 4 October 2012.
Director/PDMR
|
Number of ADSs |
Connected Person |
Number of ADSs |
Dr M M Slaoui
|
670.314 |
Dr K Slaoui |
11.992 |
Mrs D P Connelly |
325.451 |
- |
- |
Mr W C Louv |
283.937 |
- |
- |
Dr D Pulman
|
419.750 |
- |
- |
Mr D E Troy
|
167.801
|
- |
- |
The Company was advised of this information on 10 October 2012.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
11 October 2012